Drugs

NuPathe to Present at Biotech Showcase 2012

CONSHOHOCKEN, PA: ...

Cellceutix Ushers in 2012 With Plans for Clinical Trials for Anti-Cancer and Psoriasis Drugs

BEVERLY, MA: ...

The Alliance for Regenerative Medicine Reaches Goal of Welcoming 100th Member by End of 2011; Establishes European Chapter

WASHINGTON, DC: Newest Members Include Genzyme/Sanofi, Roche, Healthpoint, Life Technologies, Cellular Dynamics, Unite 2 Fight Paralysis, ReNeuron, and TiGenix ...

Sirona Biochem President Mark Senner Stepping Down

VANCOUVER, BRITISH COLUMBIA: ...

Following 1,149% Increase in Year-Over-Year Sales, Xylitol Canada Launches Xyla(TM) Brand Name for Extended Product Line

TORONTO, ONTARIO: Development Work Continues on Xylitol Manufacturing Plant Highlights - Nine month product sales increase of 1,149% over prior year to $1.31 million - Gross profit increase of 1,011% during same period ...

Phylogica and Pfizer Complete First Stage of Peptide Vaccine Collaboration

PERTH, AUSTRALIA: ...

Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias

SOUTH SAN FRANCISCO, CA: ...

Paladin Labs Announces the Canadian Launch of DigiFab(TM) Digoxin Immune Fab (Ovine)

MONTREAL, CANADA: ...

AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations

BOTHELL, WA: New Hire Is Part of Organizational Restructuring Focused on Improving Operational Efficiencies ...

Pivotal Therapeutics Receives Product License in Canada for OMAZEN(TM)

WOODBRIDGE, ONTARIO: ...